中文English
ISSN 1001-5256 (Print)
ISSN 2097-3497 (Online)
CN 22-1108/R
Volume 38 Issue 10
Oct.  2022
Turn off MathJax
Article Contents

Bacteremia in an elderly patient with cirrhotic after transjugular intrahepatic portosystemic shunt: A case report

DOI: 10.3969/j.issn.1001-5256.2022.10.025
Research funding:

Risk Assessment and Clinical Intervention of Esophageal Varices Bleeding in Liver Cirrhosis (2013YG-B009)

More Information
  • Corresponding author: QIN Jianping, qjpqing@163.com(ORCID: 0000-0001-7834-8830)
  • Received Date: 2022-01-25
  • Accepted Date: 2022-03-03
  • Published Date: 2022-10-20
  • loading
  • [1]
    HUANG S, YAO X, ZHOU H, et al. Long-term efficacy analysis of transjugular intrahepatic portosystemic shunt in the treatment of elderly patients with cirrhotic portal hypertension[J]. Pract Geriatr, 2021, 35(7): 713-717. DOI: 10.3969/j.issn.1003-9198.2021.07.013.

    黄山, 姚欣, 周昊, 等. 经颈静脉肝内门体分流术治疗老年肝硬化门静脉高压病人的长期疗效分析[J]. 实用老年医学, 2021, 35(7): 713-717. DOI: 10.3969/j.issn.1003-9198.2021.07.013.
    [2]
    LIU LL, YUAN SS, MAO JY. et al. Risk factors of nosocomial infection in patients with liver cirrhosis complicated with upper gastrointestinal bleeding and preventive measures[J]. Med & Pharm J Chin PLA, 2018, 30(8): 49-53. DOI: 10.3969/j.issn.2095-140X.2018.08.013.

    刘琳琳, 袁术生, 毛璟怡, 等. 肝硬化合并上消化道出血患者发生医院感染危险因素调查分析及预防策略[J]. 解放军医药杂志, 2018, 30(8): 49-53. DOI: 10.3969/j.issn.2095-140X.2018.08.013.
    [3]
    SANYAL AJ, REDDY KR. Vegetative infection of transjugular intrahepatic portosystemic shunts[J]. Gastroenterology, 1998, 115(1): 110-115. DOI: 10.1016/s0016-5085(98)70371-3.
    [4]
    The Chinese College of Interventionalists. CCI clinical practice guidelines: Management of TIPS for portal hypertension (2019 edition)[J]. J Clin Hepatol, 2019, 35(12): 2694-2699. DOI: 10.3969/j.issn.1001-5256.2019.12.010.

    中国医师协会介入医师分会. 中国门静脉高压经颈静脉肝内门体分流术临床实践指南(2019年版)[J]. 临床肝胆病杂志, 2019, 35(12): 2694-2699. DOI: 10.3969/j.issn.1001-5256.2019.12.010.
    [5]
    YAO X, ZHOU H, TANG SH, et al. Effect of intraoperative Viatorr stent implantation for shunting of blood flow in the left or right branch of the portal vein and its effect on clinical outcome in patients with cirrhotic portal hypertension undergoing transjugular intrahepatic portosystemic shunt[J]. J Clin Hepatol, 2020, 36(9): 1970-1974. DOI: 10.3969/j.issn. 1001-5256.2020.09.012.

    姚欣, 周昊, 汤善宏, 等. 肝硬化门静脉高压患者行经颈静脉肝内门体分流术术中置入Viatorr支架分流门静脉左、右支血流对疗效的影响[J]. 临床肝胆病杂志, 2020, 36(9): 1970-1974. DOI: 10.3969/j.issn.1001-5256.2020.09.012.
    [6]
    ZHANG L, FAN ZF, LIU DW, et al. Trend analysis on the disease burden related to cirrhosis and other chronic liver diseases caused by hepatitis B, in China, from 1990 to 2016[J]. Chin J Epidemiol, 2020, 2(41): 173-177. DOI: 10.3760/cma.j.issn.0254-6450.2020.02.007.

    张露, 范志芳, 刘殿武, 等. 1990-2016年中国乙型肝炎引起的肝硬化及其他慢性肝病疾病负担变化趋势分析[J]. 中华流行病学杂志, 2020, 2(41) : 173-177. DOI: 10.3760/cma.j.issn.0254-6450.2020.02.007.
    [7]
    RAKOSKI MO, MCCAMMON RJ, PIETTE JD, et al. Burden of cirrhosis on older Americans and their families: analysis of the health and retirement study[J]. Hepatology, 2012, 55(1): 184-191. DOI: 10.1002/hep.24616.
    [8]
    SOURABH S, SHARMA N, SHARMA R, et al. Clinical profile, severity and outcome of acute upper gastrointestinal bleeding in elderly patients compared to non-elderly patients: a prospective observational study[J]. J Assoc Physicians India, 2019, 67(9): 30-32.
    [9]
    HUANG S, YAO X, CHENG XL, et al. Early transjugular intrahepatic portal shunt for ruptured esophageal variceal bleeding in elderly cirrhotic liver[J]. Mod Digest Interv, 2021, 2(26): 197-207. DOI: 10.3969/j.issn.1672-2159.2021.02.011.

    黄山, 姚欣, 陈雪铃, 等. 早期经颈静脉肝内门体分流术治疗老年肝硬化食管静脉曲张破裂出血的临床研究[J]. 现代消化及介入诊疗, 2021, 2(26): 197-207. DOI: 10.3969/j.issn.1672-2159.2021.02.011.
    [10]
    DENG SM, ZHANG JS, QI Y, et al. Study on the application of endoscopic ligation in esophageal varices and the high risk factors of postoperative rebleeding[J]. Clin J Med Offic, 2021, 49(6): 718-720. DOI: 10.16680/j.1671-3826.2021.06.43.

    邓水苗, 张嘉星, 齐晔, 等. 内镜下套扎术在食管静脉曲张中应用及其术后再出血高危因素研究[J]. 临床军医杂志, 2021, 49(6): 718-720. DOI: 10.16680/j.1671-3826.2021.06.43.
    [11]
    BOYER TD, HASKAL ZJ, American Association for the Study of Liver Diseases. The role of transjugular intrahepatic portosystemic shunt (TIPS) in the management of portal hypertension: update 2009[J]. Hepatology, 2010, 51(1): 306. DOI: 10.1002/hep.23383.
    [12]
    BOIKE JR, THORNBURG BG, ASRANI SK, et al. North American practice-based recommendations for transjugular intrahepatic portosystemic shunts in portal hypertension[J]. Clin Gastroenterol Hepatol, 2022, 20(8): 1636-1662. e36. DOI: 10.1016/j.cgh.2021.07.018.
    [13]
    BOUZA E, MUÑOZ P, RODRÍGUEZ C, et al. Endotipsitis: an emerging prosthetic-related infection in patients with portal hypertension[J]. Diagn Microbiol Infect Dis, 2004, 49(2): 77-82. DOI: 10.1016/j.diagmicrobio.2004.03.006.
    [14]
    NAVARATNAM AM, GRANT M, BANACH DB. Endotipsitis: A case report with a literature review on an emerging prosthetic related infection[J]. World J Hepatol, 2015, 7(4): 710-716. DOI: 10.4254/wjh.v7.i4.710.
    [15]
    SAXON RR, MENDEL-HARTVIG J, CORLESS CL, et al. Bile duct injury as a major cause of stenosis and occlusion in transjugular intrahepatic portosystemic shunts: comparative histopathologic analysis in humans and swine[J]. J Vasc Interv Radiol, 1996, 7(4): 487-497. DOI: 10.1016/s1051-0443(96)70789-3.
    [16]
    HUNG ML, LEE EW. Role of Transjugular intrahepatic portosystemic shunt in the management of portal hypertension: review and update of the literature[J]. Clin Liver Dis, 2019, 23(4): 737-754. DOI: 10.1016/j.cld.2019.07.004.
    [17]
    BOIKE JR, THORNBURG BG, ASRANI SK, et al. North American practice-based recommendations for transjugular intrahepatic portosystemic shunts in portal hypertension[J]. Clin Gastroenterol Hepatol, 2022, 20(8): 1636-1662. e36. DOI: 10.1016/j.cgh.2021.07.018.
    [18]
    SUHOCKI PV, SMITH AD, TENDLER DA, et al. Treatment of TIPS/biliary fistula-related endotipsitis with a covered stent[J]. J Vasc Interv Radiol, 2008, 19(6): 937-939. DOI: 10.1016/j.jvir.2008.01.026.
    [19]
    KOMSHIAN SV, UWAYDAH AK, SOBEL JD, et al. Fungemia caused by Candida species and Torulopsis glabrata in the hospitalized patient: frequency, characteristics, and evaluation of factors influencing outcome[J]. Rev Infect Dis, 1989, 11(3): 379-390. DOI: 10.1093/clinids/11.3.379.
    [20]
    CONNOLLY JP, MITAS JA 2nd. Torulopsis glabrata fungemia in a diabetic patient[J]. South Med J, 1990, 83(3): 352-353. DOI: 10.1097/00007611-199003000-00028.
    [21]
    COMAN LI, COMAN OA, BǍDǍRǍU IA, et al. Association between liver cirrhosis and diabetes mellitus: a review on hepatic outcomes[J]. J Clin Med, 2021, 10(2): 262. DOI: 10.3390/jcm10020262.
    [22]
    CARRIER P, DEBETTE-GRATIEN M, JACQUES J, et al. Cirrhotic patients and older people[J]. World J Hepatol, 2019, 11(9): 663-677. DOI: 10.4254/wjh.v11.i9.663.
    [23]
    ADLAKHA N, RUSSO MW. Outcomes after transjugular intrahepatic portosystemic shunt in cirrhotic patients 70 years and older[J]. J Clin Med, 2020, 9(2): 381. DOI: 10.3390/jcm9020381.
    [24]
    QIN JP, JIANG MD, TANG W, et al. Clinical effects and complications of TIPS for portal hypertension due to cirrhosis: a single center[J]. World J Gastroenterol, 2013, 19(44): 8085-8092. DOI: 10.3748/wjg.v19.i44.8085.
    [25]
    HABIB G, LANCELLOTTI P, ANTUNES MJ, et al. 2015 ESC Guidelines for the management of infective endocarditis: The Task Force for the Management of Infective Endocarditis of the European Society of Cardiology (ESC). Endorsed by: European Association for Cardio-Thoracic Surgery (EACTS), the European Association of Nuclear Medicine (EANM)[J]. Eur Heart J, 2015, 36(44): 3075-3128. DOI: 10.1093/eurheartj/ehv319.
    [26]
    LOPEZ-JEREZ A, MARTIN-MATEOS R, FORTUN J, et al. Positron emission tomography for the diagnosis of tipsitis[J]. Dig Liver Dis, 2021, 53(12): 1675-1677. DOI: 10.1016/j.dld.2021.07.007.
    [27]
    BOIKE JR, THORNBURG BG, ASRANI SK, et al. North American practice-based recommendations for transjugular intrahepatic portosystemic shunts in portal hypertension[J]. Clin Gastroenterol Hepatol, 2022, 20(8): 1636-1662. e36. DOI: 10.1016/j.cgh.2021.07.018.
    [28]
    LI Y, WANG F, CHEN X, et al. Short outcome comparison of elderly patients versus nonelderly patients treated with transjugular intrahepatic portosystemic stent shunt: A propensity score matched cohort study[J]. Medicine (Baltimore), 2017, 96(29): e7551. DOI: 10.1097/MD.0000000000007551.
    [29]
    PARVINIAN A, SHAH KD, COUTURE PM, et al. Older patient age may predict early mortality after transjugular intrahepatic portosystemic shunt creation in individuals at intermediate risk[J]. J Vasc Interv Radiol, 2013, 24(7): 941-946. DOI: 10.1016/j.jvir.2013.03.018.
  • 加载中

Catalog

    通讯作者: 陈斌, bchen63@163.com
    • 1. 

      沈阳化工大学材料科学与工程学院 沈阳 110142

    1. 本站搜索
    2. 百度学术搜索
    3. 万方数据库搜索
    4. CNKI搜索

    Figures(2)

    Article Metrics

    Article views (510) PDF downloads(49) Cited by()
    Proportional views
    Related

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return